Abstract:Abstract The intestinal barrier is complex and consists of multiple layers, and it provides a physical and functional barrier to the transport of luminal contents to systemic circulation. While the epithelial cell layer and the outer/inner mucin layer constitute the physical barrier and are often referred to as the intestinal barrier, intestinal alkaline phosphatase (IAP) produced by epithelial cells and antibacterial proteins secreted by Panneth cells represent the functional barrier. While antibacterial proteins play an important role in the host defense against gut microbes, IAP detoxifies bacterial endotoxin lipopolysaccharide (LPS) by catalyzing the dephosphorylation of the active/toxic Lipid A moiety, preventing local inflammation as well as the translocation of active LPS into systemic circulation. The causal relationship between circulating LPS levels and the development of multiple diseases underscores the importance of detailed examination of changes in the “layers” of the intestinal barrier associated with disease development and how this dysfunction can be attenuated by targeted interventions. To develop targeted therapies for improving intestinal barrier function, it is imperative to have a deeper understanding of the intestinal barrier itself, the mechanisms underlying the development of diseases due to barrier dysfunction (eg, high circulating LPS levels), the assessment of intestinal barrier function under diseased conditions, and of how individual layers of the intestinal barrier can be beneficially modulated to potentially attenuate the development of associated diseases. This review summarizes the current knowledge of the composition of the intestinal barrier and its assessment and modulation for the development of potential therapies for barrier dysfunction-associated diseases.

Intestinal Failure: Pathophysiological Elements and Clinical Diseases

The Gut Microbiome and Intestinal Failure-Associated Liver Disease

Gut in Diseases: Physiological Elements and Their Clinical Significance

Intestinal Barrier Dysfunction in Inflammatory Bowel Disease: Underpinning Pathogenesis and Therapeutics

Implication of Intestinal Barrier Dysfunction in Gut Dysbiosis and Diseases

[Maintenance of Intestinal Barrier Function in Patients with Chronic Critical Illness].

Gut dysfunction in critically ill patients: a review of the literature

Mechanism of Gut-Microbiota-liver Axis in the Pathogenesis of Intestinal Failure-Associated Liver Disease

Critical Signaling Transduction Pathways and Intestinal Barrier: Implications for Pathophysiology and Therapeutics

Intestinal Barrier Dysfunction, LPS Translocation, and Disease Development

Intestinal permeation and gastrointestinal disease

Human Intestinal Barrier Function in Health and Disease

Role of gut microbiota on intestinal barrier function in acute pancreatitis

Intestinal epithelial barrier dysfunction in disease and possible therapeutical interventions

Intestinal barrier dysfunction in cirrhosis: Current concepts in pathophysiology and clinical implications.

Bile Acids, Intestinal Barrier Dysfunction, and Related Diseases

The emerging role of the gut in chronic heart failure

Integrity of the Intestinal Barrier: The Involvement of Epithelial Cells and Microbiota—A Mutual Relationship

Restore Intestinal Barrier Integrity: An Approach for Inflammatory Bowel Disease Therapy

Gut Barrier Failure in Critical Illness: Lessons Learned from Acute Pancreatitis

Direct and indirect effects of pathogenic bacteria on the integrity of intestinal barrier